STAb Therapeutics appoints Carolina Pola as Chief Executive Officer
STAb Therapeutics, a biotechnology company that develops novel immune redirecting cell therapies for cancer, announces that Dr. Carolina Pola has been appointed as CEO of the Company. Dr. Pola brings a biobusiness perspective and expertise to STAb Therapeutics to develop and deploy the strategic plan for the growth of the Company. She has developed an
STAb Therapeutics appoints Carolina Pola as Chief Executive Officer Leer más »